Polycation liposomes as a vector for potential intracellular delivery of microRNA

Journal of Gene Medicine

Volumn 15, Issue 10, 2013, Pages 375-383

  Ando, Hidenori ^a   Okamoto, Ayaka ^a   Yokota, Masafumi ^a   Asai, Tomohiro ^a   Dewa, Takehisa ^b   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Drug delivery system; Endosomal escape; Intracellular distribution; Liposomes; MicroRNA (miRNA)

Indexed keywords

LIPOSOME; MICRORNA; MICRORNA 92A; POLYCATION; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG UPTAKE; ENDOCYTOSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL;

DRUG DELIVERY SYSTEM; ENDOSOMAL ESCAPE; INTRACELLULAR DISTRIBUTION; LIPOSOMES; MICRORNA (MIRNA);

ENDOCYTOSIS; ENDOSOMES; GENE TRANSFER TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR SPACE; LIPOSOMES; MICRORNAS; POLYAMINES; TRANSFECTION;

EID: 84885939201     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2744     Document Type: Article

References (23)

1. Vicentini FT, Depieri LV, Polizello AC, et al. Liquid crystalline phase nanodispersions enable skin delivery of siRNA. Eur J Pharm Biopharm 2013; 83: 16-24.
2. Zhang G, Guo B, Wu H, et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med 2012; 18: 307-314.
3. Wei J, Cheang T, Tang B, et al. The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA. Biomaterials 2013; 34: 1246-1254.
4. Wang L, Shi J, Zhang H, et al. Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes. Biomaterials 2013; 34: 262-274.
5. Tezgel AO, Gonzalez-Perez G, Telfer JC, Osborne BA, Minter LM, Tew GN. Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells. Mol Ther 2013; 21: 201-209.
6. Nakase I, Akita H, Kogure K, et al. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Acc Chem Res 2012; 45: 1132-1139.
7. Khalil IA, Kogure K, Futaki S, Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem 2006; 281: 3544-3551.
8. Li X, Chen Y, Wang M, Ma Y, Xia W, Gu H. A mesoporous silica nanoparticle-PEI-fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials 2013; 34: 1391-1401.
9. Asai T, Matsushita S, Kenjo E, et al. Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery. Bioconjug Chem 2011; 22: 429-435.
10. Koide H, Asai T, Furuya K, et al. Inhibition of Akt (ser473) phosphorylation and rapamycin-resistant cell growth by knockdown of mammalian target of rapamycin with small interfering RNA in vascular endothelial growth factor receptor-1-targeting vector. Biol Pharm Bull 2011; 34: 602-608.
11. Yonenaga N, Kenjo E, Asai T, et al. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment. J Control Release 2012; 160: 177-181.
12. Kenjo E, Asai T, Yonenaga N, et al. Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy. Biol Pharm Bull 2013; 36: 287-291.
13. Ando H, Okamoto A, Yokota M, et al. Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy. J Gene Med 2013; 15: 20-27.
14. Semple SC, Akinc A, Chen J, et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 2010; 28: 172-176.
15. Kim JS, Oh MH, Park JY, Park TG, Nam YS. Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumour-targeting of siRNA. Biomaterials 2013; 34: 2370-2379.
16. Guo J, Cheng WP, Gu J, et al. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly L-lysine nanocarrier to suppress prostate cancer growth in mice. Eur J Pharm 2012; 45: 521-532.
17. Nakamura T, Akita H, Yamada Y, Hatakeyama H, Harashima H. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications. Acc Chem Res 2012; 45: 1113-1121.
18. Sakuma S, Suita M, Yamamoto T, et al. Performance of cell-penetrating peptide-linked polymers physically mixed with poorly membrane-permeable molecules on cell membranes. Eur J Pharm Biopharm 2012; 81: 64-73.
19. Marchini C, Pozzi D, Montani M, et al. Tailoring lipoplex composition to the lipid composition of plasma membrane a Trojan horse for cell entry? Langmuir 2010; 26: 13867-13873.
20. Cardarelli F, Pozzi D, Bifone A, Marchini C, Caracciolo G. Cholesterol-dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO living cells. Mol Pharm 2012; 9: 334-340.
21. Ilina P, Hyvonen Z, Saura M, Sandvig K, Yliperttula M, Ruponen M. Genetic blockage of endocytic pathways reveals differences in the intracellular processing of non-viral gene delivery systems. J Control Release 2012; 163: 385-395.
22. Bae YU, Kim BK, Park JW, Seu YB, Doh KO. Endocytic pathway and resistance to cholesterol depletion of cholesterol derived cationic lipids for gene delivery. Mol Pharm 2012; 9: 3579-3585.
23. Sugiyama M, Matsuura M, Takeuchi Y, Kosaka J, Nango M, Oku N. Possible mechanism of polycation liposome (PCL)-mediated gene transfer. Biochim Biophys Acta 2004; 1660: 24-30.